Filing Details
- Accession Number:
- 0001127602-19-023026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-28 16:25:20
- Reporting Period:
- 2019-06-26
- Accepted Time:
- 2019-06-28 16:25:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1231617 | Raymond Dwek | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-06-26 | 3,750 | $0.00 | 3,750 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-06-27 | 3,750 | $76.11 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Acquisiton | 2019-06-26 | 4,600 | $0.00 | 4,600 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2019-06-26 | 3,750 | $0.00 | 3,750 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,600 | 2020-06-26 | 2029-06-26 | No | 4 | A | Direct |
| 0 | No | 4 | M | Direct |
Footnotes
- Shares received upon vesting of restricted stock units on June 26, 2019. Restricted stock units converted on a one-for-one basis into shares of common stock.
- This sale of common stock was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
- Annual non-employee director grant of restricted stock units, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders.
- Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.
- The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares.
- The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares.
Billionaire Hedge Funds
